1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
  1. Launch

Bidepharm.com

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2007

Location

Shanghai China

Primary Industry

Biotechnology

About

Based in Shanghai, and established in 2007, Bidepharm.com is a biopharmaceutical company that engages in R&D, production, and sales of pharmaceutical intermediates. It provides more than 80,000 kinds of drug molecular block products, including 70,000 kinds of standing drug molecular blocks, and 12,000 kinds of self-developed and synthesized drug molecular blocks, since it was established. Its clients include new drug R&D institutions, such as Roche, Merck KGaA, Pfizer, and Syngene. In October 2022, Bidepharm.com was listed on the Shanghai Stock Exchange under the number 688073. Bidepharm.com's products can be categorized as molecular blocks and reagents. The molecular blocks include heterocyclic molecular blocks, benzene ring molecular blocks, and aliphatic molecular blocks. The reagents include catalysts, ligands catalysts, ligands, and active small molecular compounds. Those products can be used in the new drug R&D process of target discovery for new drug development, optimization, screening, and optimization of lead compounds, and identification of clinical candidates.
Current Investors
Shanghai Dongfang Yirui Investment Management Co., Ltd., Shenzhen Capital Real Estate Fund, Shanghai Tonggao Investment Management Co., LTD

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Business Support Services, Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals
Website
www.bidepharmatech.com
Company Stage
Mature
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.